Abbott Labs and Reckitt Benckiser Shares Fall

Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Abbott Labs and Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
That baby formula trial Abbott and Reckitt had won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow-milk-based formulas. NEC is a serious, and sometimes deadly, gastrointestinal disease that primarily afflicts premature infants.
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for injuries suffered by a child who consumed its formula designed for premature babies.
Reckitt moves forward with Mead Johnson infant-formula disposal
CEO Kris Licht said last week that Reckitt has received “interest” from prospective buyers for its nutrition unit housing Mead Johnson.
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Reckitt says US court grants new trial in premature-infant formula case
Reckitt said on Friday a U.S. circuit court has ruled that a new trial could be sought by plaintiffs in a case that had accused the London-listed firm and Abbott of failing to warn of the risks of premature baby formulas.
Reuters8d
Strepsils maker Reckitt misses sales forecast on late flu season, but lower costs help
LONDON, March 6 (Reuters) - Britain's Reckitt Benckiser (RKT.L), opens new tab, the maker of Strepsils throat lozenges and ...
Reckitt Benckiser Group falls Wednesday, underperforms market
Reckitt Benckiser Group PLC closed 5.02% below its 52-week high of £54.18, which the company achieved on March 7th.
Investing.com India8h
Reckitt slumps on renewed litigation uncertainty - RBC Capital Markets
In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing ...
Lysol Maker Reckitt Benckiser Beats Profit Expectations Despite Lower Sales
Adjusted profit of nearly £3.5 billion came in ahead of expectations for 2024 as the consumer-goods company continues to ...
Reckitt Benckiser downgraded to Neutral from Buy at BofA
BofA downgraded Reckitt Benckiser (RBGLY) to Neutral from Buy citing a lack of near-term catalysts and its preference for Unilever. Optimize ...
Keir Starmer plans to reshape Britain’s ‘flabby’ state. But don’t compare him to Elon Musk
Britain's Prime Minister Keir Starmer has won praise for his efforts to marshal international support for Ukraine as ...
TipRanks on MSN6d
Reckitt Benckiser price target raised to 5,600 GBp from 5,360 GBp at Barclays
Barclays analyst Iain Simpson raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,600 GBp from 5,360 GBp and ...
Reckitt Benckiser Group's Projected Earnings Seem Likely To Cover Future Distributions
Reckitt Benckiser Group plc's ( LON:RKT ) dividend will be increasing from last year's payment of the same period ...